| ASPsiRNA ID | Pairing of target region (top) and ASP-siRNA (bottom) | Efficacy (mut)(%) | Efficacy (wt) (%) | Diff | Gene | Disease | Mutation | RefSNP | Analysis | Pubmed ID |
|---|---|---|---|---|---|---|---|---|---|---|
| aspsirna2114 | UGGCGUAGGCAAGAGUGCC ACCGCAUCCGUUCUCACGG |
75 | 70 | 5 | KRAS | Cancer | c.35G>T,p.Gly12Val | rs12191352 | 
|
|
| aspsirna2115 | UGGCGUAGGCAAGAGUGCC ACCGCAUCCGUUCUCACGG |
5 | 0 | 5 | KRAS | Cancer | c.35G>T,p.Gly12Val | rs12191352 |
|
|
| aspsirna2135 | UGGCGUAGGCAAGAGUGCC ACCGCAUCCGUUCUCACGG |
75 | 70 | 5 | KRAS | Cancer | c.35G>T,p.Gly12Val | rs12191352 |
|
|
| aspsirna2136 | UGGCGUAGGCAAGAGUGCC ACCGCAUCCGUUCUCACGG |
5 | 0 | 5 | KRAS | Cancer | c.35G>T,p.Gly12Val | rs12191352 |
|
|
| aspsirna0348 | UUCCAGCUGGGAUACCUGG AAGGUCGACCCUAUGGACC |
74 | 76 | -2 | COL3A1 | Vascular Ehlers-Danlos Syndrome (vEDs) | c.764G>T,p.Gly255Val | rs58777960 |
|
|
| aspsirna3726 | GGUUGGAGGAGAGAUGAUA ACAACCUCCUCUCUACUAU |
90 | 90 | 0 | PPIB/Cyclophilin B | PPIB-Related Osteogenesis Imperfecta (Type IX) | NA | NA |
|
